Blood work for testosterone replacement therapy (TRT) confirms whether testosterone deficiency is real, identifies its likely cause, checks whether treatment is safe to start, and shows whether the prescribed dose is working. It can also detect complications, including an excessive rise in red blood cells, and guide prostate monitoring when appropriate. The Endocrine Society guidance cited here requires a documented clinical evaluation, and the first review should include at least two properly timed testosterone tests. ****
TRT should not be prescribed based on symptoms or one low testosterone result alone. A proper evaluation usually includes repeat morning testosterone testing, baseline safety tests, and a follow-up plan.
What Blood Tests Are Needed Before Starting TRT?
Before starting TRT, clinicians usually check testosterone levels, blood counts, and hormone markers that can help identify the cause of low testosterone. The exact panel depends on your age, symptoms, medical history, fertility plans, and the treatment being considered.
| Blood Test | Why It Is Used |
|---|---|
| Total testosterone | Confirms whether testosterone is consistently low |
| Free testosterone | Helps clarify borderline total testosterone results or abnormal sex hormone-binding globulin |
| LH and FSH | Helps distinguish a testicular problem from a pituitary or hypothalamic problem |
| CBC, including hemoglobin and hematocrit | Checks for an already elevated red blood cell count |
| PSA | Assesses prostate risk when PSA testing is appropriate for the patient's age and risk profile |
| Prolactin | May help identify a pituitary or hormonal cause when testosterone is low and LH is low or low-normal |
| Estradiol | Usually considered when gynecomastia, breast tenderness, or related symptoms are present |
| Metabolic tests | Liver, kidney, glucose, lipid, or other tests may be ordered based on overall health and medications |
The American Urological Association recommends two early-morning testosterone measurements, baseline hemoglobin and hematocrit, and additional tests based on the clinical situation. The Endocrine Society also recommends evaluating the cause of low testosterone rather than treating the laboratory result alone.
Why Do You Need Two Morning Testosterone Tests?
Two morning testosterone tests help confirm that the level is consistently low rather than temporarily reduced. Testosterone changes throughout the day and can fall during illness, poor nutrition, excessive exercise, sleep disruption, or certain medication use.
The Endocrine Society recommends confirming the diagnosis with at least two early-morning, fasting testosterone tests, generally collected between 7 and 10 a.m.
A single low result can lead to an incorrect diagnosis. TRT is generally considered when a patient has both compatible symptoms and consistently low testosterone levels measured with an accurate test.
How Does Blood Work Identify the Cause of Low Testosterone?
LH and FSH help show whether low testosterone is linked mainly to the testicles or to the brain's hormonal control system. TRT can replace testosterone, but it does not explain why the level is low.
A clinician may also order prolactin, iron studies, thyroid tests, or imaging, depending on the results and symptoms. Possible causes include:
- Testicular injury
- Pituitary disorders
- Certain medications
- Obesity
- Chronic illness
- Sleep disorders
- Previous chemotherapy
- Anabolic steroid use
The Endocrine Society recommends investigating the cause instead of treating the testosterone number by itself.
Why Is Hematocrit Checked Before and During TRT?
Hematocrit is checked because TRT can stimulate red blood cell production. This can raise hemoglobin and hematocrit, a condition called erythrocytosis or polycythemia.
A high hematocrit can increase blood viscosity. Depending on the result, a clinician may lower the dose, change the treatment, or pause therapy while investigating the cause.
The Endocrine Society recommends checking hematocrit before treatment, again about 3 to 6 months after starting TRT, and then annually. Its guideline recommends stopping treatment if hematocrit rises above 54%, investigating causes such as low oxygen or sleep apnea, and restarting at a lower dose when appropriate.
The AUA recommends keeping hematocrit below 54% and checking it every 6 to 12 months during stable treatment.
A high hematocrit before treatment may delay TRT while the cause is evaluated.
Why Might PSA Be Included in TRT Blood Work?
PSA may be included to assess prostate health when prostate monitoring is appropriate for the patient. PSA testing is not required in exactly the same way for everyone. The decision depends on age, prostate cancer risk, symptoms, and a discussion with a clinician.
For men who choose prostate monitoring, the Endocrine Society recommends assessing prostate risk before treatment and checking PSA again 3 to 12 months after starting TRT. A urology evaluation is recommended if:
- PSA rises by more than 1.4 ng/mL above baseline during the first year
- PSA reaches a confirmed level above 4.0 ng/mL
- An abnormal prostate finding is detected
An elevated PSA does not automatically mean prostate cancer. Benign prostate enlargement, inflammation, infection, and other conditions can also raise PSA. The result needs medical interpretation rather than an automatic decision to stop or refuse TRT.
What Is Checked After Starting TRT?
Follow-up blood work checks whether the dose is too low, too high, or appropriate. It also helps identify side effects before they become more serious.
Typical monitoring includes:
- Testosterone level: Often checked after treatment reaches a suitable steady state. The timing depends on the formulation.
- Hemoglobin and hematocrit: Commonly checked at 3 to 6 months and then at regular intervals.
- PSA: Checked when prostate monitoring is appropriate.
- Other tests: Liver, kidney, lipid, glucose, or estradiol testing may be repeated when clinically indicated.
The AUA recommends an initial follow-up testosterone test after treatment begins and testosterone testing every 6 to 12 months once levels are stable. The blood draw must be timed correctly. The useful timing differs for injections, gels, patches, pellets, and oral products.
Can Blood Work Show That the TRT Dose Is Too High?
Yes. A testosterone result above the intended treatment range may indicate excessive exposure, especially when it occurs alongside acne, mood changes, breast symptoms, fluid retention, or a high hematocrit.
The goal is usually to restore testosterone to an appropriate mid-normal range, not to push the level as high as possible. The Endocrine Society recommends reviewing symptoms, side effects, adherence, testosterone concentration, and hematocrit as part of follow-up care.
Blood pressure should also be monitored, even though it is not a blood test. The FDA required changes to testosterone product labeling after studies found increased blood pressure across testosterone products.
Is a Large TRT Blood Panel Always Necessary?
No. The right panel includes the tests needed to confirm the diagnosis, identify the cause, assess important risks, and monitor the treatment being used.
Additional tests may be reasonable if you have diabetes, obesity, liver or kidney disease, fertility concerns, breast symptoms, sleep apnea, cardiovascular risk, or medication interactions. A panel should be based on your situation rather than copied from a generic men's health package.
What If a TRT Clinic Does Not Require Blood Work?
A clinic that offers testosterone without a proper evaluation should be approached cautiously. Before treatment, the provider should complete these steps:
- Order two properly timed morning testosterone tests.
- Review your symptoms and medical history.
- Check baseline hemoglobin and hematocrit.
- Assess prostate risk when appropriate.
- Explain when repeat testing will occur and how the dose will be adjusted.
Fertility should also be discussed before starting TRT. Testosterone therapy can suppress sperm production, so it may be unsuitable for someone trying to conceive in the near future.
A TRT plan is incomplete if it includes a prescription but no baseline testing or follow-up schedule.